XPEV XPeng Inc.
Research report · from SEC EDGAR · close 2026-07-14
executive summary
XPeng Inc. (XPEV). Revenue is $895.7M at a -47% net margin. It is not yet profitable. Our health score is C (55/100). No major red flags on file. It funds itself; low dilution risk.
✓ No major red flags from our filing-based checks.
who's buying
Insider buys / sells
0 / 0
Cash & ST investments
$4.91B
Operating cash flow
-$21.4M
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-14 by stocktools.ai.